Key Events This Week
Mar 30: New 52-week low at Rs.33.44 amid continued downtrend
Apr 1: Intraday high of Rs.35.49 with a 7.16% surge
Apr 2: Continued gains, closing at Rs.37.98 (+2.07%)
Apr 3: No trading data available; week closes at Rs.37.98

Morepen Laboratories Ltd Surges 7.16% to Day's High of Rs 35.49 — Outperforms Sector by 3.3 Percentage Points
2026-04-01 09:34:17The Sensex gained 2.35% today while Morepen Laboratories Ltd surged 7.16%, outperforming its Pharmaceuticals & Biotechnology sector by 3.3 percentage points. This strong single-session performance stands out amid a broader market rally led by mega caps, raising the question of whether this is a genuine recovery or a short-lived bounce.
Read full news article
Morepen Laboratories Ltd Falls to 52-Week Low of Rs 33.44 as Sell-Off Deepens
2026-03-30 16:02:59For the second consecutive session, Morepen Laboratories Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 33.44 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper, reflecting company-specific concerns.
Read full news article
Morepen Laboratories Ltd is Rated Sell
2026-03-26 10:10:36Morepen Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 09 Feb 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Morepen Laboratories Ltd Technical Momentum Shifts Amid Bearish Signals
2026-03-17 08:02:00Morepen Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite some mildly bullish weekly indicators, the overall technical landscape suggests caution for investors as key momentum indicators and moving averages signal downward pressure on the stock price.
Read full news article









